Our findings are also in line with a previous study that revealed that TGF-β signaling enhances the migratory capacity of immortalized GBM cells, promoting a mesenchymal shift in vitro through the activation of SMAD2 and ZEB1 [177]. Here, ZEB1 is linked to glioblastoma.